Posted Tue, 28 Jun 2022 16:07:59 GMT by Cristina Pepato

Marketing authorisation holders for all authorised medicines in the EU are required to appoint a so-called industry single point of contact (i-SPOC) who can provide information directly to EMA about the supply and availability of critical medicines identified in the context of a major event or a public health emergency. This applies to products authorised via any procedure, whether centrally via EMA, or using national, mutual recognition or decetralised procedures.

They need to register an i-SPOC by 2 September 2022.

For more information, please read the announcement on the EMA Corporate website.

Registering an i-SPOC

Marketing authorisation holders need to identify their i-SPOC via EMA's IRIS platform.

They can log in to IRIS using their EMA account credentials.

Guidance on how to register an i-SPOC is available in the demo video on the EMA Corporate website, and in the user guide on the IRIS platform. Marketing authorisation holders who do not have an EMA account need to create one first via EMA's Account Management portal. This could take 5-10 working days. For technical support, they should contact the EMA Service Desk.

Posted Mon, 04 Jul 2022 11:36:53 GMT by Nikolet Doneva

Could you please clarify whether a MAH person who already has a "Industry Manager" role in IRIS can nominate himself for MAH i-SPOC? Or the nomination for i-SPOC should always be done by another MAH IRIS "manager" role?
 

Posted Thu, 07 Jul 2022 07:43:08 GMT by Caterina Scarpati

Yes, a person with "Industry manager" role can nominate himself/herself for MAH i-SPOC (only consideration is that the user should be affiliated in IAM).
 

Posted Tue, 19 Jul 2022 10:39:01 GMT by Elena Cerretini
Could you please clarify whether the iSPOC should be nominated only for CAPs or also for MRP/DCP/National products authorised in EU? Thank you very much
Posted Tue, 19 Jul 2022 11:27:42 GMT by Paolo Tomasi EMA

As reported in the initial message of this thread:

Marketing authorisation holders for all authorised medicines in the EU are required to appoint a so-called Industry single point of contact (i-SPOC) who can provide nformation directly to EMA about the supply and availability of critical medicines identified in the context of a major event or a public health emergency. This applies to products authorised via any procedure, whether centrally via EMA, or using national, mutual recognition or decentralised procedures.

Posted Tue, 23 Aug 2022 08:53:26 GMT by Isabelle Picard Head of Regulatory Operations
Even with Manager role, we don't have i-SPOC in the Submission Type list.  Shall I create an EMS ticket?
Posted Tue, 23 Aug 2022 13:18:45 GMT by Paolo Tomasi EMA
Dear Isabelle Picard, as reported in the Home page of these Forums, for access and registration requests and for reporting faults please open a request in EMA ServiceDesk providing as much information as possible (e.g. screenshots)
Posted Tue, 23 Aug 2022 15:37:22 GMT by Andrew Thornley GRA Regulatory Policy & Intelligence
We have been trying to register a colleague nominated to represent my company as i-SPOC, but she has failed so far to register herself in the IRIS Manager role, even though one of our Administrators approved the request over two weeks ago. She has raised a request with the Service Desk last week but so far, there has no resolution. Given that the deadline for nominating i-SPOCS is only a few days away, and that will involve companies that hitherto will not have registered for Industry roles in IRIS (because their product portfolios do not contain CAP products) there is a real chance that the Service Desk will receive huge numbers of requests for assistance, and that many companies will fail to meet the September 2nd deadline!
Is there a pragmatic way of informing the Agency of the i-SPOC nominee ad-interim, perhaps if at least the EMA account credentials are shared?
Thanks

You must be signed in to post in this forum.